ArticleFrontiers in pharmacology2024

Design, synthesis, and biological evaluation of 2,4-dimorpholinopyrimidine-5-carbonitrile derivatives as orally bioavailable PI3K inhibitors.

Daowei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.